Dashboard
Manage Tickers

ROIVRoivant Sciences Ltd.

Nasdaq roivant.com


$ 10.70 $ -0.12 (-1.11 %)    

Friday, 14-Jun-2024 15:59:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 10.69
$ 10.71
$ 0.00 x 0
$ 0.00 x 0
$ 10.59 - $ 10.77
$ 8.25 - $ 13.24
2,802,689
na
9.03B
$ 0.86
$ 1.95
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-30-2024 03-31-2024 10-K
2 02-13-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 06-28-2023 03-31-2023 10-K
6 02-13-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 06-28-2022 03-31-2022 10-K
10 02-14-2022 12-31-2021 10-Q
11 11-15-2021 09-30-2021 10-Q
12 09-21-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

the-analyst-verdict-roivant-sciences-in-the-eyes-of-6-experts
The Analyst Verdict: Roivant Sciences In T...
05/31/2024 14:00:16

hc-wainwright--co-reiterates-buy-on-roivant-sciences-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on Roiv...
05/31/2024 10:38:57

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $18 price ta...

roivant-sciences-q4-2024-gaap-eps-019-beats-032-estimate-sales-28930m-miss-32101m-estimate
Roivant Sciences Q4 2024 GAAP EPS $(0.19) ...
05/30/2024 11:02:13

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0....

vivek-ramaswamy-breathes-new-life-into-beaten-down-buzzfeed-stock-whats-going-on
Vivek Ramaswamy Breathes New Life Into Bea...
05/22/2024 12:04:01

BuzzFeed shares surged after Vivek Ramaswamy acquired a 7.7% stake for $3.2 million.

roivant-and-kinevant-sciences-complete-enrollment-in-resolve-lung-phase-2-study-evaluating-namilumab-for-chronic-pulmonary-sarcoidosis
Roivant And Kinevant Sciences Complete Enr...
04/25/2024 12:08:24

critical-insights-from-roivant-sciences-analyst-ratings-what-you-need-to-know
Critical Insights From Roivant Sciences An...
04/22/2024 15:01:12

hc-wainwright--co-reiterates-buy-on-roivant-sciences-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on Roiv...
04/22/2024 10:34:04

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $18 price ta...

goldman-sachs-maintains-buy-on-roivant-sciences-raises-price-target-to-18
Goldman Sachs Maintains Buy on Roivant Sci...
04/03/2024 15:18:11

Goldman Sachs analyst Corinne Jenkins maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $...

hc-wainwright--co-maintains-buy-on-roivant-sciences-raises-price-target-to-18
HC Wainwright & Co. Maintains Buy on Roiva...
04/03/2024 11:05:41

HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target...

deutsche-bank-maintains-buy-on-roivant-sciences-raises-price-target-to-15
Deutsche Bank Maintains Buy on Roivant Sci...
04/03/2024 09:14:44

Deutsche Bank analyst Neena Bitritto-Garg maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target fr...

vivek-ramaswamy-founded-roivants-anti-inflammatory-drug-aces-mid-stage-study
Vivek Ramaswamy-Founded Roivant's Anti-Inf...
04/02/2024 16:31:51

Roivant Sciences and Priovant Therapeutics report Phase 2 results for brepocitinib in treating non-anterior non-infectious uvei...

roivant-sciences-reveals-board-authorization-for-up-to-15b-share-repurchase-program-including-repurchase-of-entire-sumitomo-pharma-stake-for-648m
Roivant Sciences Reveals Board Authorizati...
04/02/2024 11:12:00

Sumitomo Pharma repurchase reduces shares outstanding by 9%

roivant-announces-positive-neptune-study-results-for-brepocitinib-in--non-infectious-uveitis
Roivant Announces Positive NEPTUNE Study R...
04/02/2024 11:10:22

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
03/29/2024 17:35:25

Core News & Articles
Roivant Sciences To Replace Sunrun In S&P ...
03/26/2024 21:20:46

where-roivant-sciences-stands-with-analysts
Where Roivant Sciences Stands With Analysts
03/25/2024 17:00:27

truist-securities-reiterates-buy-on-roivant-sciences-maintains-23-price-target
Truist Securities Reiterates Buy on Roivan...
03/25/2024 16:14:34

Truist Securities analyst Robyn Karnauskas reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $23 price target.

5-value-stocks-in-the-healthcare-sector
5 Value Stocks In The Healthcare Sector
02/19/2024 14:42:59

wolfe-research-initiates-coverage-on-roivant-sciences-with-outperform-rating-announces-price-target-of-17
Wolfe Research Initiates Coverage On Roiva...
02/15/2024 11:41:51

Wolfe Research analyst Andy Chen initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Outperform rating and announces...

the-analyst-landscape-4-takes-on-roivant-sciences
The Analyst Landscape: 4 Takes On Roivant ...
02/14/2024 17:00:57

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)